NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

胰臟·膽管支架:一般外科市場分析及預測模式

Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact).

出版商 GlobalData 商品編碼 979513
出版日期 內容資訊 英文
訂單完成後即時交付
價格
胰臟·膽管支架:一般外科市場分析及預測模式 Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact).
出版日期: 2020年10月30日內容資訊: 英文
簡介

本報告提供全球主要39個國家的胰臟·膽管支架市場調查,彙整市場及產品概要,主要的產業趨勢,用戶數(裝置量),新銷售數,平均銷售價格等各種資料及其轉變,產品的年度收益變化與預測,競爭環境與企業佔有率,分析師的各種分析等資料。

主要的調查內容

  • 目前上市的胰臟·膽管支架產品·競爭情形
  • 主要的產業趨勢回顧
  • 年度收益的轉變·預測:各種區分
    • 經內視鏡逆行性膽胰管攝影術(ERCP)
    • 經皮穿肝膽管造影術(PTC)
  • 各種詳細資料
    • 用戶數(裝置量)
    • 新銷售數
    • 平均銷售價格
    • 市場規模
    • 企業佔有率
  • 分析師分析

本報告書的優點

  • 通過審查管道產品和技術並確定擁有可靠管道的公司,可以建立和設計引入授權和對外授權策略。
  • 通過了解形成並促進產品市場的趨勢,可以訂定業務策略。
  • 通過進一步了解關鍵趨勢,創新產品和技術,有影響力的公司等來提高利潤。
  • 通過了解競爭環境並分析市場領導者的佔有率,可以建立有效的銷售和營銷策略。
  • 確定具有潛在強大產品組合的新興參與者,並製定有效的對策以獲得競爭優勢。
  • 可以追蹤·預測世界·各國設備銷售情況。
  • 通過鎖定能提供最大機會進行合併,投資和戰略合作的市場類別和細分來使銷售/營銷工作系統化。

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME605MM

Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact). is built to visualize quantitative market trends within General Surgery therapeutic area.

Pancreatic and Biliary stents are the tubular devices made either of plastic or metal. They are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These stents are also for preventing post- endoscopic retrograde cholangiopancreatography pancreatitis and to drain the gallbladder and pancreatic fluids. These stents are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).

The Pancreatic and biliary stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts. Increase in the number of ERCP and PTC procedures has fueled the market especially the procedures requiring stenting and recurrent stenting.

Disorders of the biliary duct effect a major portion of the world and it is increasing every year which is evidenced by increase in the number of ERCP procedures. Biliary obstruction from malignant causes is quite common, with as many 70% of the pancreatic cancer patients presenting with obstruction upon diagnosis. Every year more than 500,000 ERCP procedures including diagnostic as well as surgical, are carried out alone in the United States.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Pancreatic and Biliary stent and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Pancreatic and Biliary stent market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Pancreatic and Biliary stent market.
  • Competitive dynamics insights and trends provided for Pancreatic and Biliary stent market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Cook Group Inc, Cardinal Health Inc, Medtronic plc, ConMed Corp, W. L. Gore & Associates Inc, Taewoong Medical Co Ltd, Olympus Corp, Becton Dickinson and Co, Micro-Tech (Nanjing) Co Ltd, ELLA-CS sro, Abbott Laboratories, Endo-Flex GmbH, Hobbs Medical Inc , Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Pancreatic and Biliary stent marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Pancreatic and Biliary stent market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Pancreatic and Biliary stent market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Pancreatic and Biliary stent market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Pancreatic and Biliary stent market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.